Effects of cetirizine on isolated rat's tracheal smooth muscle

Chuan Hsiang Kao, Yueng Hsiang Chu, Hsing Won Wang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cetirizine (Zytec) is often used as a histamine receptor-1 (H1) antagonist in rhinitis patients who are suffering from sneezing and rhinorrhea. This H1 antagonist is used as an oral tablet or nasal spray solution. The effect of H1 antagonist on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has been rarely explored. Therefore, during administration of the H1 antagonist for nasal symptoms, it might also affect the trachea via oral intake or inhalation. We used our preparation to test the effectiveness of Zytec on isolated rat's tracheal smooth muscle. The following assessments of Zytec were performed: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 5 × 10-6 M methacholine as a parasympathetic mimetic; (3) effect of the drug on electrically induced tracheal smooth muscle contractions. Results indicated that addition of a parasympathetic mimetic to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of Zytec at doses of 10-5 M or above elicited a relaxation response to 5 × 10-6 M methacholine-induced contraction. Zytec could inhibit electrical field stimulation induced spike contraction, and basal tension was increased at the same time. However, it alone had a minimal effect on the basal tension of trachea as the concentration increased. This study indicated that high concentrations of Zytec might actually inhibit parasympathetic function of the trachea.

Original languageEnglish
Pages (from-to)753-757
Number of pages5
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume266
Issue number5
DOIs
Publication statusPublished - May 2009
Externally publishedYes

Fingerprint

Cetirizine
Histamine Receptors
Trachea
Smooth Muscle
Methacholine Chloride
Oral Sprays
Sneezing
Nasal Sprays
Muscle Tonus
Nasal Mucosa
Rhinitis
Muscle Contraction
Nose
Pharmaceutical Preparations
Inhalation
Electric Stimulation
Tablets

Keywords

  • Cetirizine
  • In vitro study
  • Smooth muscle
  • Trachea

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Effects of cetirizine on isolated rat's tracheal smooth muscle. / Kao, Chuan Hsiang; Chu, Yueng Hsiang; Wang, Hsing Won.

In: European Archives of Oto-Rhino-Laryngology, Vol. 266, No. 5, 05.2009, p. 753-757.

Research output: Contribution to journalArticle

Kao, Chuan Hsiang ; Chu, Yueng Hsiang ; Wang, Hsing Won. / Effects of cetirizine on isolated rat's tracheal smooth muscle. In: European Archives of Oto-Rhino-Laryngology. 2009 ; Vol. 266, No. 5. pp. 753-757.
@article{a6556be207b84617bebbc6b41dfeabb1,
title = "Effects of cetirizine on isolated rat's tracheal smooth muscle",
abstract = "Cetirizine (Zytec) is often used as a histamine receptor-1 (H1) antagonist in rhinitis patients who are suffering from sneezing and rhinorrhea. This H1 antagonist is used as an oral tablet or nasal spray solution. The effect of H1 antagonist on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has been rarely explored. Therefore, during administration of the H1 antagonist for nasal symptoms, it might also affect the trachea via oral intake or inhalation. We used our preparation to test the effectiveness of Zytec on isolated rat's tracheal smooth muscle. The following assessments of Zytec were performed: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 5 × 10-6 M methacholine as a parasympathetic mimetic; (3) effect of the drug on electrically induced tracheal smooth muscle contractions. Results indicated that addition of a parasympathetic mimetic to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of Zytec at doses of 10-5 M or above elicited a relaxation response to 5 × 10-6 M methacholine-induced contraction. Zytec could inhibit electrical field stimulation induced spike contraction, and basal tension was increased at the same time. However, it alone had a minimal effect on the basal tension of trachea as the concentration increased. This study indicated that high concentrations of Zytec might actually inhibit parasympathetic function of the trachea.",
keywords = "Cetirizine, In vitro study, Smooth muscle, Trachea",
author = "Kao, {Chuan Hsiang} and Chu, {Yueng Hsiang} and Wang, {Hsing Won}",
year = "2009",
month = "5",
doi = "10.1007/s00405-008-0838-y",
language = "English",
volume = "266",
pages = "753--757",
journal = "European Archives of Oto-Rhino-Laryngology",
issn = "0937-4477",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Effects of cetirizine on isolated rat's tracheal smooth muscle

AU - Kao, Chuan Hsiang

AU - Chu, Yueng Hsiang

AU - Wang, Hsing Won

PY - 2009/5

Y1 - 2009/5

N2 - Cetirizine (Zytec) is often used as a histamine receptor-1 (H1) antagonist in rhinitis patients who are suffering from sneezing and rhinorrhea. This H1 antagonist is used as an oral tablet or nasal spray solution. The effect of H1 antagonist on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has been rarely explored. Therefore, during administration of the H1 antagonist for nasal symptoms, it might also affect the trachea via oral intake or inhalation. We used our preparation to test the effectiveness of Zytec on isolated rat's tracheal smooth muscle. The following assessments of Zytec were performed: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 5 × 10-6 M methacholine as a parasympathetic mimetic; (3) effect of the drug on electrically induced tracheal smooth muscle contractions. Results indicated that addition of a parasympathetic mimetic to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of Zytec at doses of 10-5 M or above elicited a relaxation response to 5 × 10-6 M methacholine-induced contraction. Zytec could inhibit electrical field stimulation induced spike contraction, and basal tension was increased at the same time. However, it alone had a minimal effect on the basal tension of trachea as the concentration increased. This study indicated that high concentrations of Zytec might actually inhibit parasympathetic function of the trachea.

AB - Cetirizine (Zytec) is often used as a histamine receptor-1 (H1) antagonist in rhinitis patients who are suffering from sneezing and rhinorrhea. This H1 antagonist is used as an oral tablet or nasal spray solution. The effect of H1 antagonist on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has been rarely explored. Therefore, during administration of the H1 antagonist for nasal symptoms, it might also affect the trachea via oral intake or inhalation. We used our preparation to test the effectiveness of Zytec on isolated rat's tracheal smooth muscle. The following assessments of Zytec were performed: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 5 × 10-6 M methacholine as a parasympathetic mimetic; (3) effect of the drug on electrically induced tracheal smooth muscle contractions. Results indicated that addition of a parasympathetic mimetic to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of Zytec at doses of 10-5 M or above elicited a relaxation response to 5 × 10-6 M methacholine-induced contraction. Zytec could inhibit electrical field stimulation induced spike contraction, and basal tension was increased at the same time. However, it alone had a minimal effect on the basal tension of trachea as the concentration increased. This study indicated that high concentrations of Zytec might actually inhibit parasympathetic function of the trachea.

KW - Cetirizine

KW - In vitro study

KW - Smooth muscle

KW - Trachea

UR - http://www.scopus.com/inward/record.url?scp=63049103650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63049103650&partnerID=8YFLogxK

U2 - 10.1007/s00405-008-0838-y

DO - 10.1007/s00405-008-0838-y

M3 - Article

VL - 266

SP - 753

EP - 757

JO - European Archives of Oto-Rhino-Laryngology

JF - European Archives of Oto-Rhino-Laryngology

SN - 0937-4477

IS - 5

ER -